Stemgent Raises $14 Million

Stemgent Inc., a Cambridge, Mass.-based provider of stem cell technologies and research tools, has raised $14 million in Series A-1 funding, according to a regulatory filing. Backers include HealthCare Ventures and Morgenthaler Ventures. www.stemgent.com

Related Posts

Leave a Reply

PEHUB Community

Join the 12493 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups